Amneal Pharmaceuticals, Inc. announced that it has appointed David A. Buchen to the newly expanded role of Senior Vice President, Chief Legal Officer and Corporate Secretary, reporting to President and Chief Executive Officer Robert Stewart. Mr. Buchen will be responsible for leading Amneal's global legal, Intellectual Property (IP) and corporate compliance functions, as well as aligning the company's corporate legal strategies to drive Amneal's continued growth. Most recently, Mr. Buchen served as a consultant to the pharmaceutical industry, providing counsel to various global and U.S. manufacturing, marketing and distribution companies. To ensure a smooth leadership transition, Amneal's Senior Vice President, General Counsel, Sheldon Hirt, will remain on board through January 2019 before leaving the company to pursue other opportunities.